🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

Oil Up, Buoyed by Vaccine Hopes Despite Large Crude Oil Build

Published 12/09/2020, 11:01 PM
Updated 12/09/2020, 11:04 PM
© Reuters.
PFE
-
LCO
-
CL
-
BNTX
-

By Gina Lee

Investing.com – Oil was up on Thursday morning in Asia, with the U.K.’s rollout of a COVID-19 vaccine and the imminent arrival of the same vaccine in the U.S. spurring hopes of a recovery in fuel demand and eclipsing a larger-than-expected build in U.S. crude stocks during the previous week.

Brent oil futures were up 0.53% to $49.12 by 101:59 PM ET (3:59 AM GMT) and WTI futures rose 0.62% to $45.80. Prices saw little change overnight but remained above the $40 mark.

A plunge in U.S. crude exports to their lowest level since 2018 saw an unusually large build in U.S. crude stocks. Data from the U.S. Energy Information Administration (EIA) released overnight showed a 15.189-million-barrel build for the week to Dec. 4, much bigger than the 1.424-million-barrel draw in forecasts prepared by Investing.com and the previous week’s 679,000-barrel draw.

The EIA data follows that released by the American Petroleum Institute on Tuesday showing a 1.141-million-barrel build in U.S. crude oil supplies, also bigger than the forecast 1.514-million-barrel draw but down from the previous week’s 4.146-million-barrel build.

However, some investors remained optimistic despite the data.

“Optimism over the vaccine prevails and continues to limit any serious downside action,” Axi chief market strategist Stephen Innes said in a note.

Driving optimism for investors such as Innes are COVID-19 vaccines. The U.S. Food and Drug Administration (FDA) will meet later in the day to discuss BNT162b2, the COVID-19 vaccine co-developed by Pfizer (NYSE:PFE) and BioNTech SE (F:22UAy). Should the FDA grant emergency use authorization during its meeting which is widely expected, distribution could begin as soon as 24 hours after the decision, Health & Human Services Secretary Alex Azar has said.

Health Canada gave its nod to the vaccine on Wednesday, following the U.K.’s Medicines & Healthcare Products Regulatory Agency (MHRA)’s temporary authorization for emergency use issued during the previous week. Although the U.K. has already inoculated its first patients, MHRA has warned that anyone with a history of anaphylaxis to a medicine or food should not be inoculated.

Also boosting oil prices was investor jitters following the incineration of two wells at a small oilfield in northern Iraq, described by the government as a “terrorist attack”.

Although the incident has not impacted production at the oilfield, some investors expressed concern.

“While the wells were small, it has raised concerns of further disruptions,” ANZ Research said in a note.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.